Skip to main content
Clinical Trials/ACTRN12617001544369
ACTRN12617001544369CompletedPhase 4

Effect of pharmaceutical dopaminergic enhancement on performance in a complex optimisation task in healthy adults

The University of Melbourne0 sites32 target enrollmentStarted: November 7, 2017Last updated:
Conditions

Trial Snapshot

Phase
Phase 4
Status
Completed
Enrollment
32

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional
Allocation
Randomised controlled trial
Primary Purpose
Treatment
Masking
Blinded (masking used)

Eligibility Criteria

Ages
18 Years to 35 Years (—)
Sex
All

Inclusion Criteria

  • Healthy volunteers aged between 18 and 35 years old.

Exclusion Criteria

  • History of psychiatric or neurological illness including epilepsy, head injury, previous use of psychotropic medication, history of significant drug use, heart conditions (including high blood pressure, defined as above 140 mm/Hg systolic and/or 90 mm/Hg diastolic pressure as measured at the initial assessment session) pregnancy, or glaucoma. Any family history of sudden death of a first degree relative through cardiac or unknown causes before the age of 50 years old will also exclude the participant.

Investigators

Similar Trials